Downregulation of Sec23A Protein by miRNA-375 in Prostate Carcinoma
暂无分享,去创建一个
Arndt Hartmann | E. Kremmer | A. Hartmann | S. Wach | B. Wullich | R. Stöhr | F. Grässer | Elisabeth Kremmer | Bernd Wullich | Sven Wach | Elke Nolte | Jaroslaw Szczyrba | Robert Stöhr | Wolf Wieland | W. Wieland | Friedrich A Grässer | E. Nolte | Jaroslaw Szczyrba
[1] Dieter Jocham,et al. A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer. , 2010, Urologic oncology.
[2] A. Schetter,et al. MicroRNA Expression in Squamous Cell Carcinoma and Adenocarcinoma of the Esophagus: Associations with Survival , 2009, Clinical Cancer Research.
[3] P. Falkai,et al. The LARK/RBM4a protein is highly expressed in cerebellum as compared to cerebrum , 2008, Neuroscience Letters.
[4] J. Steitz,et al. Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5′ UTR as in the 3′ UTR , 2007, Proceedings of the National Academy of Sciences.
[5] Gunter Meister,et al. miRNAs Get an Early Start on Translational Silencing , 2007, Cell.
[6] Arndt Hartmann,et al. The MicroRNA Profile of Prostate Carcinoma Obtained by Deep Sequencing , 2010, Molecular Cancer Research.
[7] B. Seliger,et al. Association of HLA class I antigen abnormalities with disease progression and early recurrence in prostate cancer , 2010, Cancer Immunology, Immunotherapy.
[8] H. Trompeter,et al. Role of DNA methylation in miR-200c/141 cluster silencing in invasive breast cancer cells , 2010, BMC Research Notes.
[9] G. Goodall,et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1 , 2008, Nature Cell Biology.
[10] C. Croce,et al. SnapShot: MicroRNAs in Cancer , 2009, Cell.
[11] R. Aharonov,et al. A diagnostic assay based on microRNA expression accurately identifies malignant pleural mesothelioma. , 2010, The Journal of molecular diagnostics : JMD.
[12] Enrica Calura,et al. Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections. , 2011, The Lancet. Oncology.
[13] Yvonne Tay,et al. MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation , 2008, Nature.
[14] Y. Lu,et al. Combination of hsa-miR-375 and hsa-miR-142-5p as a predictor for recurrence risk in gastric cancer patients following surgical resection. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.
[15] W. Criekinge,et al. The N‐myc downstream regulated gene (NDRG) family: diverse functions, multiple applications , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[16] Arif B Ekici,et al. MicroRNA profiles of prostate carcinoma detected by multiplatform microRNA screening , 2012, International journal of cancer.
[17] Y. Jun,et al. Receptor‐Mediated ER Export of Human MHC Class I Molecules Is Regulated by the C‐Terminal Single Amino Acid , 2011, Traffic.
[18] Jianmin Si,et al. MiR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2 , 2010, Cell Research.
[19] M. Okoniewski,et al. microRNA profiling in Epstein–Barr virus-associated B-cell lymphoma , 2010, Nucleic acids research.
[20] K. Ohuchida,et al. MicroRNA, hsa-miR-200c, is an independent prognostic factor in pancreatic cancer and its upregulation inhibits pancreatic cancer invasion but increases cell proliferation , 2010, Molecular Cancer.
[21] C. Croce,et al. Epigenetically deregulated microRNA-375 is involved in a positive feedback loop with estrogen receptor alpha in breast cancer cells. , 2010, Cancer research.
[22] P. Stern,et al. Loss of HLA class I expression in prostate cancer: implications for immunotherapy. , 1995, Urology.
[23] Randy Schekman,et al. Coordination of COPII vesicle trafficking by Sec23. , 2008, Trends in cell biology.
[24] J. Christopher Fromme,et al. The genetic basis of a craniofacial disease provides insight into COPII coat assembly. , 2007, Developmental cell.
[25] R. Schekman,et al. COPII: A membrane coat formed by Sec proteins that drive vesicle budding from the endoplasmic reticulum , 1994, Cell.
[26] H. Allgayer,et al. Loss of miR-200c Expression Induces an Aggressive, Invasive, and Chemoresistant Phenotype in Non–Small Cell Lung Cancer , 2010, Molecular Cancer Research.
[27] David J. Stephens,et al. Assembly, organization, and function of the COPII coat , 2007, Histochemistry and Cell Biology.
[28] Norbert Senninger,et al. EP300—A miRNA‐regulated metastasis suppressor gene in ductal adenocarcinomas of the pancreas , 2010, International journal of cancer.
[29] K. Roemer,et al. Epstein–Barr virus-encoded microRNA miR-BART2 down-regulates the viral DNA polymerase BALF5 , 2007, Nucleic acids research.
[30] M. Seto,et al. MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta. , 2010, Cancer research.
[31] Laura Pelletier,et al. MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations , 2008, Hepatology.
[32] Brock C Christensen,et al. MicroRNA Expression Ratio Is Predictive of Head and Neck Squamous Cell Carcinoma , 2009, Clinical Cancer Research.
[33] E. Howe,et al. Loss of miR-200c: A Marker of Aggressiveness and Chemoresistance in Female Reproductive Cancers , 2009, Journal of oncology.
[34] R. Schekman,et al. Cloning and functional characterization of mammalian homologues of the COPII component Sec23. , 1996, Molecular biology of the cell.
[35] M. Frotscher,et al. Secretory COPII coat component Sec23a is essential for craniofacial chondrocyte maturation , 2006, Nature Genetics.
[36] Daniel B. Martin,et al. Circulating microRNAs as stable blood-based markers for cancer detection , 2008, Proceedings of the National Academy of Sciences.
[37] G. Hurteau,et al. Stable expression of miR-200c alone is sufficient to regulate TCF8 (ZEB1) and restore E-cadherin expression , 2009, Cell cycle.
[38] C. Tepper,et al. microRNAs and prostate cancer , 2008, Journal of cellular and molecular medicine.